| pubmed-article:17894005 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:17894005 | lifeskim:mentions | umls-concept:C0683971 | lld:lifeskim |
| pubmed-article:17894005 | lifeskim:mentions | umls-concept:C0003241 | lld:lifeskim |
| pubmed-article:17894005 | lifeskim:mentions | umls-concept:C0086981 | lld:lifeskim |
| pubmed-article:17894005 | lifeskim:mentions | umls-concept:C0332281 | lld:lifeskim |
| pubmed-article:17894005 | lifeskim:mentions | umls-concept:C0102561 | lld:lifeskim |
| pubmed-article:17894005 | pubmed:dateCreated | 2007-9-25 | lld:pubmed |
| pubmed-article:17894005 | pubmed:abstractText | The significance of antibodies against alpha-fodrin compared to antibodies against Ro (SSA) as markers of Sjögren's syndrome has been controversially discussed. We therefore compared the association of alpha-fodrin and Ro antibodies with dry eyes and dry mouth in the general population. In 168 "normal" participants, the prevalence of IgA antibodies against alpha-fodrin was 5% and of IgG antibodies against alpha-fodrin was 3%. IgA antibodies against alpha-fodrin were present in 3 of 4 and IgG antibodies against alpha-fodrin in 2 of 4 participants with the combination of dry eyes and dry mouth (P = 0.0002 and 0.005). Only one participant had antibodies against Ro and had dry eyes but normal saliva production. Antibodies against alpha-fodrin are associated with sicca syndrome and may be valuable diagnostic markers in patients with Sjögren's syndrome lacking Ro antibodies. | lld:pubmed |
| pubmed-article:17894005 | pubmed:language | eng | lld:pubmed |
| pubmed-article:17894005 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17894005 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:17894005 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17894005 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17894005 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17894005 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17894005 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17894005 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17894005 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17894005 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17894005 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:17894005 | pubmed:month | Jun | lld:pubmed |
| pubmed-article:17894005 | pubmed:issn | 0077-8923 | lld:pubmed |
| pubmed-article:17894005 | pubmed:author | pubmed-author:SchmidtReinho... | lld:pubmed |
| pubmed-article:17894005 | pubmed:author | pubmed-author:WitteTorstenT | lld:pubmed |
| pubmed-article:17894005 | pubmed:author | pubmed-author:MatthiasTorst... | lld:pubmed |
| pubmed-article:17894005 | pubmed:author | pubmed-author:BierwirthJani... | lld:pubmed |
| pubmed-article:17894005 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:17894005 | pubmed:volume | 1108 | lld:pubmed |
| pubmed-article:17894005 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:17894005 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:17894005 | pubmed:pagination | 414-7 | lld:pubmed |
| pubmed-article:17894005 | pubmed:meshHeading | pubmed-meshheading:17894005... | lld:pubmed |
| pubmed-article:17894005 | pubmed:meshHeading | pubmed-meshheading:17894005... | lld:pubmed |
| pubmed-article:17894005 | pubmed:meshHeading | pubmed-meshheading:17894005... | lld:pubmed |
| pubmed-article:17894005 | pubmed:meshHeading | pubmed-meshheading:17894005... | lld:pubmed |
| pubmed-article:17894005 | pubmed:meshHeading | pubmed-meshheading:17894005... | lld:pubmed |
| pubmed-article:17894005 | pubmed:meshHeading | pubmed-meshheading:17894005... | lld:pubmed |
| pubmed-article:17894005 | pubmed:meshHeading | pubmed-meshheading:17894005... | lld:pubmed |
| pubmed-article:17894005 | pubmed:meshHeading | pubmed-meshheading:17894005... | lld:pubmed |
| pubmed-article:17894005 | pubmed:meshHeading | pubmed-meshheading:17894005... | lld:pubmed |
| pubmed-article:17894005 | pubmed:meshHeading | pubmed-meshheading:17894005... | lld:pubmed |
| pubmed-article:17894005 | pubmed:year | 2007 | lld:pubmed |
| pubmed-article:17894005 | pubmed:articleTitle | Antibodies against alpha-fodrin are associated with sicca syndrome in the general population. | lld:pubmed |
| pubmed-article:17894005 | pubmed:affiliation | Department of Clinical Immunology, Medical School Hannover, Hannover, Germany. witte.torsten@mh-hannover.de | lld:pubmed |
| pubmed-article:17894005 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:17894005 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17894005 | lld:pubmed |
